Gault CR and Obeid LM |
Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. |
2011 |
Crit. Rev. Biochem. Mol. Biol. |
pmid:21787121
|
Noguchi K and Chun J |
Roles for lysophospholipid S1P receptors in multiple sclerosis. |
2011 |
Crit. Rev. Biochem. Mol. Biol. |
pmid:20979571
|
Rohrbach T et al. |
Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. |
2017 |
Crit. Rev. Biochem. Mol. Biol. |
pmid:28618839
|
Pulkoski-Gross MJ et al. |
Sphingosine-1-phosphate metabolism: A structural perspective. |
2015 |
Crit. Rev. Biochem. Mol. Biol. |
pmid:25923252
|
Huwiler A and Zangemeister-Wittke U |
Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. |
2007 |
Crit. Rev. Oncol. Hematol. |
pmid:17560117
|
Takeo T et al. |
Investigations of motility and fertilization potential in thawed cryopreserved mouse sperm from cold-stored epididymides. |
2014 |
Cryobiology |
pmid:24201107
|
Chakrabarti SS et al. |
Ceramide and Sphingosine-1-Phosphate in Cell Death Pathways : Relevance to the Pathogenesis of Alzheimer's Disease. |
2016 |
Curr Alzheimer Res |
pmid:27335046
|
Sanchez T |
Sphingosine-1-Phosphate Signaling in Endothelial Disorders. |
2016 |
Curr Atheroscler Rep |
pmid:27115142
|
Herr DR and Chun J |
Effects of LPA and S1P on the nervous system and implications for their involvement in disease. |
2007 |
Curr Drug Targets |
pmid:17266539
|
Zeidan YH et al. |
Molecular targeting of acid ceramidase: implications to cancer therapy. |
2008 |
Curr Drug Targets |
pmid:18691012
|
Jacobson JR and Garcia JG |
Novel therapies for microvascular permeability in sepsis. |
2007 |
Curr Drug Targets |
pmid:17430121
|
Cuvillier O et al. |
Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. |
2010 |
Curr Mol Pharmacol |
pmid:20302564
|
Choueiri TK et al. |
Phenoxodiol: isoflavone analog with antineoplastic activity. |
2006 |
Curr Oncol Rep |
pmid:16507219
|
Peavy RD and Metcalfe DD |
Understanding the mechanisms of anaphylaxis. |
2008 |
Curr Opin Allergy Clin Immunol |
pmid:18596587
|
Black JL and Johnson PR |
Factors controlling smooth muscle proliferation and airway remodelling. |
2002 |
Curr Opin Allergy Clin Immunol |
pmid:11964750
|
Rosen H and Liao J |
Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm. |
2003 |
Curr Opin Chem Biol |
pmid:12941420
|
Cusack KP and Stoffel RH |
S1P(1) receptor agonists: Assessment of selectivity and current clinical activity. |
2010 |
Curr Opin Drug Discov Devel |
pmid:20597031
|
Hinkovska-Galcheva V et al. |
The role of sphingosine-1-phosphate and ceramide-1-phosphate in calcium homeostasis. |
2008 |
Curr Opin Investig Drugs |
pmid:18951299
|
Chatterjee S et al. |
The role of the phospholipid sphingomyelin in heart disease. |
2006 |
Curr Opin Investig Drugs |
pmid:16555682
|
Elices MJ |
Editorial overview: Tie me up, tie me down: immunosuppressive therapies for the 21st century. |
2004 |
Curr Opin Investig Drugs |
pmid:15573862
|
Kennedy S et al. |
Targeting sphingosine-1-phosphate signalling for cardioprotection. |
2009 |
Curr Opin Pharmacol |
pmid:19070545
|
Peters SL and Alewijnse AE |
Sphingosine-1-phosphate signaling in the cardiovascular system. |
2007 |
Curr Opin Pharmacol |
pmid:17280869
|
Brinkmann V and Baumruker T |
Pulmonary and vascular pharmacology of sphingosine 1-phosphate. |
2006 |
Curr Opin Pharmacol |
pmid:16563863
|
Bolli MH et al. |
Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls. |
2011 |
Curr Top Med Chem |
pmid:21261590
|
Osborne N et al. |
The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish. |
2008 |
Curr. Biol. |
pmid:19062281
|
Slattum G et al. |
Autophagy in oncogenic K-Ras promotes basal extrusion of epithelial cells by degrading S1P. |
2014 |
Curr. Biol. |
pmid:24361067
|
Brownlee C |
Intracellular signalling: sphingosine-1-phosphate branches out. |
2001 |
Curr. Biol. |
pmid:11470429
|
Xia P et al. |
An oncogenic role of sphingosine kinase. |
2000 |
Curr. Biol. |
pmid:11114522
|
Hoofnagle AN et al. |
HDL lipids and insulin resistance. |
2010 |
Curr. Diab. Rep. |
pmid:20425071
|
Delgado A and MartÃnez-Cartro M |
Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors. |
2016 |
Curr. Med. Chem. |
pmid:26639095
|
He S et al. |
Self-amplification mechanisms of mast cell activation: a new look in allergy. |
2012 |
Curr. Mol. Med. |
pmid:22920722
|
Pitman MR et al. |
Molecular targets of FTY720 (fingolimod). |
2012 |
Curr. Mol. Med. |
pmid:22834825
|
Weiner OD |
Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass. |
2002 |
Curr. Opin. Cell Biol. |
pmid:11891119
|
Bendall LJ and Basnett J |
Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells. |
2013 |
Curr. Opin. Hematol. |
pmid:23507960
|
Borup A et al. |
Apolipoprotein M in lipid metabolism and cardiometabolic diseases. |
2015 |
Curr. Opin. Lipidol. |
pmid:25551802
|
Christoffersen C and Nielsen LB |
Apolipoprotein M: bridging HDL and endothelial function. |
2013 |
Curr. Opin. Lipidol. |
pmid:23652568
|
Egom EE et al. |
HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL. |
2013 |
Curr. Opin. Lipidol. |
pmid:23652570
|
Abdel-Latif A et al. |
Lysophospholipids in coronary artery and chronic ischemic heart disease. |
2015 |
Curr. Opin. Lipidol. |
pmid:26270808
|
Jessup W |
Lipid metabolism: sources and stability of plasma sphingosine-1-phosphate. |
2008 |
Curr. Opin. Lipidol. |
pmid:18769238
|
Tamama K and Okajima F |
Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology. |
2002 |
Curr. Opin. Lipidol. |
pmid:12352012
|
Huwiler A and Pfeilschifter J |
Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy. |
2006 |
Curr. Pharm. Des. |
pmid:17168766
|
Yatomi Y |
Sphingosine 1-phosphate in vascular biology: possible therapeutic strategies to control vascular diseases. |
2006 |
Curr. Pharm. Des. |
pmid:16472149
|
Tölle M et al. |
Relevance of sphingolipids in the pleiotropic protective effects of high-density lipoproteins. |
2010 |
Curr. Pharm. Des. |
pmid:20196741
|
Fogarty CE and Bergmann A |
The Sound of Silence: Signaling by Apoptotic Cells. |
2015 |
Curr. Top. Dev. Biol. |
pmid:26431570
|
Rosen H et al. |
The organization of the sphingosine 1-phosphate signaling system. |
2014 |
Curr. Top. Microbiol. Immunol. |
pmid:24728591
|
Hanson MA and Peach R |
Structural biology of the S1P1 receptor. |
2014 |
Curr. Top. Microbiol. Immunol. |
pmid:24728592
|
Cahalan SM |
Chemical and genetic tools to explore S1P biology. |
2014 |
Curr. Top. Microbiol. Immunol. |
pmid:24728593
|
Arnon TI and Cyster JG |
Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen. |
2014 |
Curr. Top. Microbiol. Immunol. |
pmid:24728595
|
Oldstone MB and Rosen H |
Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. |
2014 |
Curr. Top. Microbiol. Immunol. |
pmid:24728596
|
Xiong Y and Hla T |
S1P control of endothelial integrity. |
2014 |
Curr. Top. Microbiol. Immunol. |
pmid:24728594
|